Ergoteles’s iShares US Medical Devices ETF IHI Stock Holding History

Ergoteles’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-55,702	Closed	-$2.81M	–	1731
2022 Q2	$2.81M	Buy	+55,702	New	+$3.04M	0.08%	240

Other funds holding IHI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

MIH

Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ergoteles's IHI Position: Q3 2022 in Review

Ergoteles sold out of iShares US Medical Devices ETF (IHI) in Q3 2022, closing a stake of 55,702 shares — an estimated $2.81M sold.

Ergoteles first reported a position in IHI in Q2 2022 and held it in 1 quarter. The position peaked at $2.81M in Q2 2022. 556 funds tracked by Wall St. Rank hold IHI as of Q3 2022.

Ergoteles reported no remaining iShares US Medical Devices ETF position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 55,702 iShares US Medical Devices ETF shares in Q3 2022, an estimated $2.81M.
Ergoteles first reported a position in iShares US Medical Devices ETF in Q2 2022 and held it in 1 quarter.
Ergoteles's iShares US Medical Devices ETF position peaked at $2.81M in Q2 2022.
556 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.